This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Radtke, A.
Right arrow Articles by Bevanger, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Radtke, A.
Right arrow Articles by Bevanger, L. S.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, September 2001, p. 3420-3421, Vol. 39, No. 9
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.9.3420-3421.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Peritoneal Dialysis-Associated Peritonitis Caused by Dermabacter hominis

Andreas Radtke,1,* Kåre Bergh,1,2 Cecilia M. Øien,3 and Lars S. Bevanger1,2

Department of Microbiology1 and Department of Nephrology,3 Regional Hospital, and Department of Laboratory Medicine, Norwegian University of Science and Technology,2 Trondheim, Norway

Received 19 March 2001/Returned for modification 16 May 2001/Accepted 10 July 2001

Dermabacter hominis was the cause of a peritoneal dialysis-associated peritonitis. D. hominis was identified by phenotypic criteria and by sequencing the 16S rRNA gene. Clinical cure was achieved with cefuroxime treatment despite the isolate's reduced susceptibility to this drug (MIC, 12 mg/liter) on in vitro testing. The successful treatment was probably due to the high concentrations attained by intraperitoneal administration of the drug.

* Corresponding author. Mailing address: Department of Microbiology, Regional Hospital, N-7006 Trondheim, Norway. Phone: 47 73867470. Fax: 47 73867765. E-mail: anrad{at}gmx.net.

Journal of Clinical Microbiology, September 2001, p. 3420-3421, Vol. 39, No. 9
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.9.3420-3421.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Renvoise, A., Aldrovandi, N., Raoult, D., Roux, V. (2009). Helcobacillus massiliensis gen. nov., sp. nov., a novel representative of the family Dermabacteraceae isolated from a patient with a cutaneous discharge. Int. J. Syst. Evol. Microbiol. 59: 2346-2351 [Abstract] [Full Text]  
  • de Vin, F., Rutherford, P., Faict, D. (2009). INTRAPERITONEAL ADMINISTRATION OF DRUGS IN PERITONEAL DIALYSIS PATIENTS: A REVIEW OF COMPATIBILITY AND GUIDANCE FOR CLINICAL USE. pdi 29: 5-15 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»